A study published by Kueck and colleagues assessing the effect of RSV on the viability and glucose uptake on five human ovarian cancer cell lines found that treatments of up to 8 hours were able to reduce glucose uptake, lactate production, Akt, and mammalian target of rapamycin (mTOR) signaling and cell viability in a dose- and time-dependent manner [42,43]. This evidence concerns the gene AKT1 and ovarian cancer.